First-year results of the International Leukemia/Lymphoma Target Board for pediatric relapsed and refractory hematological malignancies

Key Points

• To assess the effectiveness of targeted interventions for pediatric patients with relapsed or refractory hematological malignancies.
• International collaboration to evaluate treatment strategies
• Focus on relapsed and refractory cases
• Data collection on patient outcomes
• Outcomes from first-year observations reported
• Improved strategies for treatment emerge
• Potential trends in effectiveness noted